Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease

Abstract Aims The number of patients with both chronic obstructive pulmonary disease (COPD) and heart failure (HF) is increasing in Asia, and these conditions often coexist. We previously revealed a tendency of beta‐blocker underuse among patients with HF with reduced ejection fraction (HFrEF) and C...

Full description

Bibliographic Details
Main Authors: Yoshiaki Kubota, Wan Ting Tay, Tiew‐Hwa Katherine Teng, Kuniya Asai, Takashi Noda, Kengo Kusano, Atsushi Suzuki, Nobuhisa Hagiwara, Shinji Hisatake, Takanori Ikeda, Ryobun Yasuoka, Takashi Kurita, Wataru Shimizu, ASIAN‐HF Executive Committee
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:ESC Heart Failure
Subjects:
Chronic obstructive pulmonary disease
Heart failure
Beta‐blocker
Online Access:https://doi.org/10.1002/ehf2.13489

Internet

https://doi.org/10.1002/ehf2.13489

Similar Items